Technological innovations promote cancer stem cell-based translational research

Area of Science:

• Oncology
• Cancer Biology
• Stem Cell Research

Background:

• Cancer stem cells (CSCs) are a key driver of therapy resistance and tumor recurrence.
• CSCs exhibit enhanced survival mechanisms, including apoptosis evasion, metabolic flexibility, and DNA repair.
• The tumor microenvironment (TME) critically supports CSC survival and therapeutic resistance.

Purpose of the Study:

• To provide a comprehensive overview of cancer stem cells (CSCs).
• To explore the role of the tumor microenvironment (TME) in supporting CSCs.
• To discuss CSC-based therapeutic strategies informed by recent technological advancements.

Main Methods:

• Review of current literature on cancer stem cells (CSCs) and the tumor microenvironment (TME).
• Integration of insights from recent technological developments, including single-cell sequencing, functional genomics, organ chip platforms, and artificial intelligence (AI).
• Analysis of molecular regulatory mechanisms governing CSCs.

Main Results:

• CSCs possess unique abilities contributing to treatment failure.
• The TME provides essential support for CSC maintenance and therapy resistance.
• Technological advancements are improving the understanding and targeting of CSCs.

Conclusions:

• Targeting CSCs and their TME is crucial for overcoming cancer therapy resistance.
• Emerging technologies offer new avenues for developing effective CSC-based therapies.
• Future research should focus on leveraging these technologies for clinical translation.